Skip to main content
Top
Published in: European Journal of Clinical Microbiology & Infectious Diseases 4/2020

01-04-2020 | Human Immunodeficiency Virus | Original Article

Population-based risk factors for community-onset bloodstream infections

Authors: Kevin B. Laupland, Kelsey Pasquill, Gabrielle Dagasso, Elizabeth C. Parfitt, Lisa Steele, Henrik C. Schonheyder

Published in: European Journal of Clinical Microbiology & Infectious Diseases | Issue 4/2020

Login to get access

Abstract

Although a number of comorbidities have been associated with development of bloodstream infection, actual risk factors have not been well defined and quantified in nonselected populations. We sought to quantify population-based risk factors for development of community-onset bloodstream infection (COBSI). Surveillance was conducted among all residents of the Western Interior of British Columbia, Canada, during 2011–2018. Risks were expressed as incidence rate ratios (IRR) with 95% confidence intervals (CI). The annual incidence was 147.1 per 100,000 and older individuals, and males were at overall higher risk. The median Charlson score was 2 (IQR, 0–3), and this was higher among those with healthcare-associated (2; IQR, 1–4) as compared to community-associated (1; IQR, 0–2; P < 0.0001) COBSI. Risk factors for development of COBSI included (IRR; 95% CI): HIV infection (8.89; 5.17–14.27), cancer (6.80; 6.13–7.54), congestive heart failure (4.68; 4.00–5.46), dementia (3.31; 2.82–3.87), diabetes mellitus (3.10; 2.80–3.42), cerebrovascular accident (2.79; 2.34–3.31), renal dysfunction (2.75; 2.33–3.22), chronic lung disease (2.03; 1.79–2.28), peripheral vascular disease (1.68; 1.39–2.01), and rheumatic disease (1.44; 1.14–1.79). Patients with multiple comorbid illnesses were older, more likely to be male, and have healthcare-associated BSI, higher rates of antimicrobial resistance, and different clinical foci of infection. A number of demographic and comorbid conditions significantly increase the risk for development of COBSI.
Literature
1.
go back to reference Goto M, Al-Hasan MN (2013) Overall burden of bloodstream infection and nosocomial bloodstream infection in North America and Europe. Clin Microbiol Infect 19(6):501–509CrossRef Goto M, Al-Hasan MN (2013) Overall burden of bloodstream infection and nosocomial bloodstream infection in North America and Europe. Clin Microbiol Infect 19(6):501–509CrossRef
2.
go back to reference Friedman ND, Kaye KS, Stout JE, McGarry SA, Trivette SL, Briggs JP, Lamm W, Clark C, MacFarquhar J, Walton AL, Reller LB, Sexton DJ (2002) Health care--associated bloodstream infections in adults: a reason to change the accepted definition of community-acquired infections. Ann Intern Med 137(10):791–797CrossRef Friedman ND, Kaye KS, Stout JE, McGarry SA, Trivette SL, Briggs JP, Lamm W, Clark C, MacFarquhar J, Walton AL, Reller LB, Sexton DJ (2002) Health care--associated bloodstream infections in adults: a reason to change the accepted definition of community-acquired infections. Ann Intern Med 137(10):791–797CrossRef
3.
go back to reference Laupland KB, Church DL (2014) Population-based epidemiology and microbiology of community-onset bloodstream infections. Clin Microbiol Rev 27(4):647–664CrossRef Laupland KB, Church DL (2014) Population-based epidemiology and microbiology of community-onset bloodstream infections. Clin Microbiol Rev 27(4):647–664CrossRef
4.
go back to reference Morin CA, Hadler JL (2001) Population-based incidence and characteristics of community-onset Staphylococcus aureus infections with bacteremia in 4 metropolitan Connecticut areas, 1998. J Infect Dis 184(8):1029–1034CrossRef Morin CA, Hadler JL (2001) Population-based incidence and characteristics of community-onset Staphylococcus aureus infections with bacteremia in 4 metropolitan Connecticut areas, 1998. J Infect Dis 184(8):1029–1034CrossRef
5.
go back to reference Mehl A, Asvold BO, Lydersen S, Paulsen J, Solligard E, Damas JK, Harthug S, Edna TH (2017) Burden of bloodstream infection in an area of mid-Norway 2002-2013: a prospective population-based observational study. BMC Infect Dis 17(1):205CrossRef Mehl A, Asvold BO, Lydersen S, Paulsen J, Solligard E, Damas JK, Harthug S, Edna TH (2017) Burden of bloodstream infection in an area of mid-Norway 2002-2013: a prospective population-based observational study. BMC Infect Dis 17(1):205CrossRef
6.
go back to reference Uslan DZ, Crane SJ, Steckelberg JM, Cockerill FR 3rd, St Sauver JL, Wilson WR, Baddour LM (2007) Age- and sex-associated trends in bloodstream infection: a population-based study in Olmsted County, Minnesota. Arch Intern Med 167(8):834–839CrossRef Uslan DZ, Crane SJ, Steckelberg JM, Cockerill FR 3rd, St Sauver JL, Wilson WR, Baddour LM (2007) Age- and sex-associated trends in bloodstream infection: a population-based study in Olmsted County, Minnesota. Arch Intern Med 167(8):834–839CrossRef
7.
go back to reference Laupland KB, Gregson DB, Flemons WW, Hawkins D, Ross T, Church DL (2007) Burden of community-onset bloodstream infection: a population-based assessment. Epidemiol Infect 135(6):1037–1042CrossRef Laupland KB, Gregson DB, Flemons WW, Hawkins D, Ross T, Church DL (2007) Burden of community-onset bloodstream infection: a population-based assessment. Epidemiol Infect 135(6):1037–1042CrossRef
8.
go back to reference Laupland KB, Kibsey PC, Gregson DB, Galbraith JC (2013) Population-based laboratory assessment of the burden of community-onset bloodstream infection in Victoria, Canada. Epidemiol Infect 141(1):174–180CrossRef Laupland KB, Kibsey PC, Gregson DB, Galbraith JC (2013) Population-based laboratory assessment of the burden of community-onset bloodstream infection in Victoria, Canada. Epidemiol Infect 141(1):174–180CrossRef
9.
go back to reference Sogaard M, Norgaard M, Dethlefsen C, Schonheyder HC (2011) Temporal changes in the incidence and 30-day mortality associated with bacteremia in hospitalized patients from 1992 through 2006: a population-based cohort study. Clin Infect Dis 52(1):61–69CrossRef Sogaard M, Norgaard M, Dethlefsen C, Schonheyder HC (2011) Temporal changes in the incidence and 30-day mortality associated with bacteremia in hospitalized patients from 1992 through 2006: a population-based cohort study. Clin Infect Dis 52(1):61–69CrossRef
10.
go back to reference Laupland KB, Pasquill K, Parfitt EC, Naidu P, Steele L (2016) Burden of community-onset bloodstream infections, Western Interior, British Columbia, Canada. Epidemiol Infect 144(11):2440–2446CrossRef Laupland KB, Pasquill K, Parfitt EC, Naidu P, Steele L (2016) Burden of community-onset bloodstream infections, Western Interior, British Columbia, Canada. Epidemiol Infect 144(11):2440–2446CrossRef
11.
go back to reference Thomsen RW, Riis AH, Kjeldsen S, Schonheyder HC (2011) Impact of diabetes and poor glycaemic control on risk of bacteraemia with haemolytic streptococci groups A, B, and G. J Infect 63(1):8–16CrossRef Thomsen RW, Riis AH, Kjeldsen S, Schonheyder HC (2011) Impact of diabetes and poor glycaemic control on risk of bacteraemia with haemolytic streptococci groups A, B, and G. J Infect 63(1):8–16CrossRef
12.
go back to reference Thulstrup AM, Sorensen HT, Schonheyder HC, Moller JK, Tage-Jensen U (2000) Population-based study of the risk and short-term prognosis for bacteremia in patients with liver cirrhosis. Clin Infect Dis 31(6):1357–1361CrossRef Thulstrup AM, Sorensen HT, Schonheyder HC, Moller JK, Tage-Jensen U (2000) Population-based study of the risk and short-term prognosis for bacteremia in patients with liver cirrhosis. Clin Infect Dis 31(6):1357–1361CrossRef
13.
go back to reference Dagasso G, Conley J, Parfitt E, Pasquill K, Steele L, Laupland K (2018) Risk factors associated with bloodstream infections in end-stage renal disease patients: a population-based study. Infect Dis (Lond) 50(11-12):831–836CrossRef Dagasso G, Conley J, Parfitt E, Pasquill K, Steele L, Laupland K (2018) Risk factors associated with bloodstream infections in end-stage renal disease patients: a population-based study. Infect Dis (Lond) 50(11-12):831–836CrossRef
14.
go back to reference Giske CG, Wisell KT, Ternhag A, Naucler P, Isendahl J (2019) Risk factors for community-onset bloodstream infections with extended spectrum beta-lactamase-producing Enterobacteriaceae: a national population-based case-control study. Clin Microbiol Infect 25(11)1408–1414. Giske CG, Wisell KT, Ternhag A, Naucler P, Isendahl J (2019) Risk factors for community-onset bloodstream infections with extended spectrum beta-lactamase-producing Enterobacteriaceae: a national population-based case-control study. Clin Microbiol Infect 25(11)1408–1414.
15.
go back to reference Paulsen J, Askim A, Mohus RM, Mehl A, Dewan A, Solligard E, Damas JK, Asvold BO (2017) Associations of obesity and lifestyle with the risk and mortality of bloodstream infection in a general population: a 15-year follow-up of 64 027 individuals in the HUNT Study. Int J Epidemiol 46(5):1573–1581CrossRef Paulsen J, Askim A, Mohus RM, Mehl A, Dewan A, Solligard E, Damas JK, Asvold BO (2017) Associations of obesity and lifestyle with the risk and mortality of bloodstream infection in a general population: a 15-year follow-up of 64 027 individuals in the HUNT Study. Int J Epidemiol 46(5):1573–1581CrossRef
16.
go back to reference Laupland KB (2013) Defining the epidemiology of bloodstream infections: the 'gold standard' of population-based assessment. Epidemiol Infect 141(10):2149–2157CrossRef Laupland KB (2013) Defining the epidemiology of bloodstream infections: the 'gold standard' of population-based assessment. Epidemiol Infect 141(10):2149–2157CrossRef
17.
go back to reference Al-Hasan MN, Eckel-Passow JE, Baddour LM (2011) Influence of referral bias on the clinical characteristics of patients with Gram-negative bloodstream infection. Epidemiol Infect 139(11):1750–1756CrossRef Al-Hasan MN, Eckel-Passow JE, Baddour LM (2011) Influence of referral bias on the clinical characteristics of patients with Gram-negative bloodstream infection. Epidemiol Infect 139(11):1750–1756CrossRef
18.
go back to reference Charlson ME, Pompei P, Ales KL, MacKenzie CR (1987) A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40(5):373–383CrossRef Charlson ME, Pompei P, Ales KL, MacKenzie CR (1987) A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40(5):373–383CrossRef
20.
go back to reference Davies HD, McGeer A, Schwartz B, Green K, Cann D, Simor AE, Low DE (1996) Invasive group A streptococcal infections in Ontario, Canada. Ontario Group A Streptococcal Study Group. N Engl J Med 335(8):547–554CrossRef Davies HD, McGeer A, Schwartz B, Green K, Cann D, Simor AE, Low DE (1996) Invasive group A streptococcal infections in Ontario, Canada. Ontario Group A Streptococcal Study Group. N Engl J Med 335(8):547–554CrossRef
23.
go back to reference Ellison LF, Wilkins K (2012) Canadian trends in cancer prevalence. Health Rep 23(1):7–16PubMed Ellison LF, Wilkins K (2012) Canadian trends in cancer prevalence. Health Rep 23(1):7–16PubMed
27.
go back to reference Arora P, Vasa P, Brenner D, Iglar K, McFarlane P, Morrison H, Badawi A (2013) Prevalence estimates of chronic kidney disease in Canada: results of a nationally representative survey. CMAJ 185(9):E417–E423CrossRef Arora P, Vasa P, Brenner D, Iglar K, McFarlane P, Morrison H, Badawi A (2013) Prevalence estimates of chronic kidney disease in Canada: results of a nationally representative survey. CMAJ 185(9):E417–E423CrossRef
29.
go back to reference Lovell M, Harris K, Forbes T, Twillman G, Abramson B, Criqui MH, Schroeder P, Mohler ER 3rd, Hirsch AT, Peripheral Arterial Disease C (2009) Peripheral arterial disease: lack of awareness in Canada. Can J Cardiol 25(1):39–45CrossRef Lovell M, Harris K, Forbes T, Twillman G, Abramson B, Criqui MH, Schroeder P, Mohler ER 3rd, Hirsch AT, Peripheral Arterial Disease C (2009) Peripheral arterial disease: lack of awareness in Canada. Can J Cardiol 25(1):39–45CrossRef
31.
go back to reference Mohus RM, Paulsen J, Gustad L, Askim A, Mehl A, DeWan AT, Afset JE, Asvold BO, Solligard E, Damas JK (2018) Association of iron status with the risk of bloodstream infections: results from the prospective population-based HUNT Study in Norway. Intensive Care Med 44(8):1276–1283CrossRef Mohus RM, Paulsen J, Gustad L, Askim A, Mehl A, DeWan AT, Afset JE, Asvold BO, Solligard E, Damas JK (2018) Association of iron status with the risk of bloodstream infections: results from the prospective population-based HUNT Study in Norway. Intensive Care Med 44(8):1276–1283CrossRef
32.
go back to reference Skov Dalgaard L, Norgaard M, Jespersen B, Jensen-Fangel S, Ostergaard LJ, Schonheyder HC, Sogaard OS (2015) Risk and prognosis of bloodstream infections among patients on chronic hemodialysis: a population-based cohort study. PLoS One 10(4):e0124547CrossRef Skov Dalgaard L, Norgaard M, Jespersen B, Jensen-Fangel S, Ostergaard LJ, Schonheyder HC, Sogaard OS (2015) Risk and prognosis of bloodstream infections among patients on chronic hemodialysis: a population-based cohort study. PLoS One 10(4):e0124547CrossRef
33.
go back to reference Sogaard M, Norgaard M, Pedersen L, Sorensen HT, Schonheyder HC (2011) Blood culture status and mortality among patients with suspected community-acquired bacteremia: a population-based cohort study. BMC Infect Dis 11:139CrossRef Sogaard M, Norgaard M, Pedersen L, Sorensen HT, Schonheyder HC (2011) Blood culture status and mortality among patients with suspected community-acquired bacteremia: a population-based cohort study. BMC Infect Dis 11:139CrossRef
34.
go back to reference Thomsen RW, Hundborg HH, Lervang HH, Johnsen SP, Schonheyder HC, Sorensen HT (2005) Diabetes mellitus as a risk and prognostic factor for community-acquired bacteremia due to enterobacteria: a 10-year, population-based study among adults. Clin Infect Dis 40(4):628–631CrossRef Thomsen RW, Hundborg HH, Lervang HH, Johnsen SP, Schonheyder HC, Sorensen HT (2005) Diabetes mellitus as a risk and prognostic factor for community-acquired bacteremia due to enterobacteria: a 10-year, population-based study among adults. Clin Infect Dis 40(4):628–631CrossRef
35.
go back to reference Laupland KB, Ross T, Gregson DB (2008) Staphylococcus aureus bloodstream infections: risk factors, outcomes, and the influence of methicillin resistance in Calgary, Canada, 2000-2006. J Infect Dis 198(3):336–343CrossRef Laupland KB, Ross T, Gregson DB (2008) Staphylococcus aureus bloodstream infections: risk factors, outcomes, and the influence of methicillin resistance in Calgary, Canada, 2000-2006. J Infect Dis 198(3):336–343CrossRef
36.
go back to reference Inghammar M, Engstrom G, Ljungberg B, Lofdahl CG, Roth A, Egesten A (2014) Increased incidence of invasive bacterial disease in chronic obstructive pulmonary disease compared to the general population--a population based cohort study. BMC Infect Dis 14:163CrossRef Inghammar M, Engstrom G, Ljungberg B, Lofdahl CG, Roth A, Egesten A (2014) Increased incidence of invasive bacterial disease in chronic obstructive pulmonary disease compared to the general population--a population based cohort study. BMC Infect Dis 14:163CrossRef
Metadata
Title
Population-based risk factors for community-onset bloodstream infections
Authors
Kevin B. Laupland
Kelsey Pasquill
Gabrielle Dagasso
Elizabeth C. Parfitt
Lisa Steele
Henrik C. Schonheyder
Publication date
01-04-2020
Publisher
Springer Berlin Heidelberg
Published in
European Journal of Clinical Microbiology & Infectious Diseases / Issue 4/2020
Print ISSN: 0934-9723
Electronic ISSN: 1435-4373
DOI
https://doi.org/10.1007/s10096-019-03777-8

Other articles of this Issue 4/2020

European Journal of Clinical Microbiology & Infectious Diseases 4/2020 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.